Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 96,876 |
|
|||||
| News | - | ||||||
| Day High | 34.625 | Low High |
|||||
| Day Low | 32.27 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings Inc | CRBP | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.75 | 2.24% | 34.25 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 33.33 | 32.27 | 34.625 | 34.25 | 33.50 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,148 | 96,876 | US$ 33.73 | US$ 3,267,197 | - | 3.0334 - 49.8699 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:34:14 | 1 | US$ 34.97 | USD |
Corbus Pharmaceuticals Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 359.49M | 10.49M | - | 0 | -44.6M | -4.25 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Corbus Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRBP Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 35.79 | 40.08 | 32.0288 | 37.21 | 248,018 | -1.54 | -4.30% |
| 1 Month | 39.24 | 45.00 | 32.0288 | 38.71 | 236,035 | -4.99 | -12.72% |
| 3 Months | 26.36 | 49.8699 | 20.21 | 35.61 | 298,871 | 7.89 | 29.93% |
| 6 Months | 5.72 | 49.8699 | 3.0334 | 29.60 | 505,047 | 28.53 | 498.78% |
| 1 Year | 9.01 | 49.8699 | 3.0334 | 28.78 | 262,600 | 25.24 | 280.13% |
| 3 Years | 52.50 | 68.70 | 2.11 | 19.93 | 1,305,882 | -18.25 | -34.76% |
| 5 Years | 215.10 | 322.50 | 2.11 | 64.86 | 2,195,639 | -180.85 | -84.08% |
Corbus Pharmaceuticals Description
| Corbus Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for endocannabinoid or immune system. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. |
